APOA1 and chronic myelogenous leukemia, BCR-ABL1 positive: On the other hand, the CML+apoA-I group showed lower AST and ALT levels (442 IU/L and 197 IU/L, respectively), which were 15% and 22% lower than CML+PBS group, respectively.